Author:
Nagalla Srikanth,Ballas Samir K
Reference110 articles.
1. Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia;Ataga;Blood,2008
2. Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043);Ataga;British Journal of Haematology,2011
3. Efficacy of zinc therapy in prevention of crisis in sickle cell anemia: a double blind, randomized controlled clinical trial;Gupta;Journal of the Association of Physicians of India,1995
4. The effect of megestrol acetate on sickling;Adadevoh;American Journal of the Medical Sciences,1973
5. Rheothrx (Poloxamer 188) injection for the acute painful episode of sickle cell disease (SCD): a pilot study [abstract];Adams-Graves,1995
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献